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Yersinia pestis in 
Pulex irritans  
Fleas during  
Plague Outbreak, 
Madagascar
To the Editor: Yersinia pestis 
(family Enterobacteriaceae) is a bac-
terium that can cause high rates of 
death in susceptible mammals and can 
provoke septicemic, pneumonic, and 
bubonic plague in humans (1). This 
zoonotic pathogen can be transmitted 
directly by infectious droplets or by 
contact with contaminated fluid or tis-
sue or indirectly through flea bites (1).
Plague was introduced into Mad-
agascar in 1898 from rat-infested 
steamships that had sailed from affect-
ed areas (2). Now, Madagascar is 1 of 
2 countries in Africa that have report-
ed cases of human plague every year 
since 1991 (3). During January 2008–
January 2013, the number of human 
plague cases reported in Madagascar 
ranged from 312 to 648 per year. Of 
these, 61.8%–75.5% were laboratory 
confirmed (National Plague Labora-
tory of the Ministry of Health, pers. 
comm.). Most (>83%) confirmed cas-
es were bubonic plague, which most 
commonly results from flea bites, 
suggesting that these bites were the 
most common mode of Y. pestis trans-
mission. In Madagascar, Xenopsylla 
cheopis fleas have been known as the 
primary plague vector in urban areas, 
whereas Synopsyllus fonquerniei fleas 
have been usually involved in plague 
transmission in rural areas (2). 
In January 2013, a total of 9 sus-
pected bubonic plague cases, 3 con-
firmed, were reported in Soavina, a 
rural area in the district of Ambatofi-
nandrana, Madagascar. Domestic fleas 
were collected with candle traps inside 
5 houses during 3 nights (Table). Fleas 
were also caught on small mammals 
trapped inside houses and outside in the 
sisal fences and rice fields (Table). A 
total of 319 fleas belonging to 5 species 
in 5 genera were collected inside and 
outside the houses, an average of 44 per 
house (maximum 71): Pulex irritans, 
Echidnophaga gallinacea, and Cteno-
cephalides canis fleas were collected 
inside the houses (244, 76.5%), and S. 
fonquerniei and X. cheopis fleas were 
collected outside (75, 23.5%). The hu-
man flea, P. irritans, was the most col-
lected flea species (233, 73.3%), fol-
lowed by S. fonquerniei (62, 19.4%), X. 
cheopis (13, 4.1%), E. gallinacea (10, 
3.1%), and C. canis (1, 0.3%).
Bacterial DNA was extracted 
from 277 fleas of 5 species: 233 P. 
irritans, 24 S. fonquerniei, 9 X. cheo-
pis, 10 E. gallinacea, and 1 C. canis. 
PCR to detect Y. pestis was performed 
by using primers YP1 (5′-ATC TTA 
CTT TCC GTG AGA AG-3′) and YP2 
(5′-CTT GGA TGT TGA GCT TCC 
TA-3′) to amplify a 478-bp fragment 
(4). Y. pestis DNA was then amplified 
and genotyped by Beckman Coul-
ter Genomics Inc. (Takeley, United 
Kingdom). The positive control was Y. 
pestis reference strain (strain 6/69, 3 
× 108 bacteria/mL; Institut Pasteur de 
Madagascar).
Detection of Y. pestis was carried 
out on 274 fleas belonging to 5 flea 
species: 230 P. irritans (181 unfed and 
49 engorged), 24 S. fonquerniei (15 
unfed and 9 engorged), 9 X. cheopis 
(8 unfed and 1 engorged), 10 E. galli-
nacea (blood-feeding status not iden-
tified), and 1 unfed C. canis. Y. pestis 
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Species Total	no.	(%) No.	(%)	inside No.	(%)	outside 
Pulex irritans 233	(73.0) 233	(95.5) 0 
Ctenocephalides canis 1	(0.3) 1	(0.4) 0 
Echidnophaga gallinacea 10	(3.1) 10	(4.1) 0 
Synopsyllus fonquerniei 62	(19.4) 0 62	(82.7) 
Xenopsylla cheopis 13	(4.1) 0 13	(17.3) 
Total 319	(100) 244	(100) 75	(100) 
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was detected in 9 P. irritans fleas (7 
male [6 unfed and 1 engorged] and 2 
[engorged] female) from 3 houses, in-
cluding the house where a confirmed 
human case of plague had occurred 
(online Technical Appendix, http://
wwwnc.cdc.gov/EID/article/20/8/13-
0629-Techapp1.pdf). Eight sequences 
(GenBank accession nos. KJ361938–
KJ361945) were obtained and share 
99% nucleotide homology with plas-
minogen activator genes of Y. pestis 
published in GenBank (accession nos. 
AF528537, AY305870). No Y. pestis 
was detected in the 24 S. fonquerniei, 
9 X. cheopis, 10 E. gallinacea, or 1 C. 
canis fleas collected. 
Although only X. cheopis and S. 
fonqueniei fleas had previously been 
described as plague vectors in Mada-
gascar, P. irritans fleas were most 
commonly collected during this field 
study; engorged and unfed male and 
female P. irritans fleas carried Y. pes-
tis. Other studies have found P. irri-
tans fleas in the plague risk area in oth-
er countries in Africa (5,6); one study 
found that P. irritans fleas may play a 
role in plague epidemiology in Tanza-
nia (5). Data on P. irritans fleas in rats 
make it unlikely that these fleas are 
involved in rat-to-human transmis-
sion of Y. pestis in Madagascar. Dur-
ing 1922–1995, a total of 118,608 rats 
were caught and examined in Mada-
gascar, but only 148 P. irritans fleas 
were identified, and none have been 
found on rats since 1996 (http://www.
pasteur.mg/spip.php?rubrique124). 
The high density of P. irritans fleas 
we observed in villages where plague 
outbreaks occurred in late 2012 and 
early 2013 (http://www.pasteur.mg/
spip.php?rubrique124) supports the 
possibility that P. irritans fleas played 
a role in domestic human-to-human 
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Serologic  
Surveillance for 
West Nile Virus  
in Dogs, Africa
To the Editor: West Nile fe-
ver is caused by the West Nile virus 
(WNV), a mosquito-borne member 
of the genus Flavivirus. Birds are 
the natural reservoir of the virus, 
which is maintained in nature in a 
mosquito–bird–mosquito transmis-
sion cycle. WNV has been detected 
in many regions worldwide, includ-
ing North America, Europe, Africa, 
the Near East, and Asia (1). WNV 
has been shown to cause meningoen-
cephalitis in humans and horses. In 
the United States, seroconversion in 
dogs was detected 6 weeks before a 
human case was reported (2). Thus, 
dogs could be considered as sentinels 
for WNV infection, but their role as 
reservoir is unlikely because of short-
term and low levels of viremia (3). 
In this study, we determined the se-
roprevalence of WNV in dogs living 
close to humans in different environ-
ments to assess their role as sentinels 
of this potentially severe zoonosis.
During 2003–2012, blood sam-
ples were collected from 753 adult 
dogs from France and 6 countries in 
Africa (Table). Samples were cen-
trifuged within 24 h after collection, 
separated, frozen at –20°C, and sent 
to the virology laboratory of the In-
stitut de Recherche Biomédicale des 
Armées (Marseille, France). Each 
sample was systematically tested for 
IgG against WNV by using an in-
house ELISA with inactivated WNV 
as antigen. Serum samples were con-
sidered positive if the optical density 
at 450 nm was >3-fold the mean of 
that for negative antigen. Because of 
the antigenic cross-reactivity among 
flaviviruses, all positive samples were 
further tested by Western blot for 
WNV-specific antibodies (4); serop-
revalence was calculated on the basis 
of Western blot–confirmed cases only. 
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